Blocking chondrocyte hypertrophy in conditional Evc knockout mice does not modify cartilage damage in osteoarthritis

Area of Science:

• Biochemistry
• Genetics
• Orthopedics

Background:

• Chondrocytes in osteoarthritis (OA) cartilage exhibit a hypertrophic phenotype, with Hedgehog (Hh) signaling playing a key role.
• Hh pathway dysregulation is implicated in OA pathogenesis, while mutations in EVC/EVC2 genes cause Ellis-van Creveld syndrome.

Purpose of the Study:

• To investigate Ellis-van Creveld syndrome protein (Evc) as a potential therapeutic target for OA.
• To determine if Evc deletion prevents chondrocyte hypertrophy and joint damage in an OA mouse model.

Main Methods:

• Osteoarthritis was induced in wild-type and Evc knockout mice via surgical destabilization.
• Gene expression of hypertrophic markers and Hh pathway components was analyzed using qRT-PCR.
• Metalloproteinase levels were assessed by western blot; human OA chondrocytes were used for in vitro studies.

Main Results:

• Tamoxifen-induced Evc inactivation partially inhibited Hh overexpression and chondrocyte hypertrophy in OA mice.
• Evc deletion did not ameliorate cartilage damage in the destabilized knee model.
• Hh pathway inhibition did not affect IL-1 beta-induced inflammatory mediators in human OA chondrocytes.

Conclusions:

• Evc inactivation partially prevents chondrocyte hypertrophy in OA but does not prevent cartilage damage.
• Chondrocyte hypertrophy may not be a primary pathogenic event driving OA progression.